Payment overview · 2025
General Payments
$18.82
1 reported records · 1 companies
Healthcare provider profile · identity verified
John A Reyes, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · OYSTER BAY, NY · NPI 1295888709
Verified facts
What the public records show
CMS Open Payments records show John A Reyes, M.D. received $18.82 in general payments during 2025 across 1 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $18.82 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.82 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $18.82 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $18.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1117 | 228 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1048 | 256 |
| Amlodipine Besylate | Amlodipine Besylate | 620 | 153 |
| Metoprolol Succinate | Metoprolol Succinate | 554 | 138 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 516 | 171 |
| Eliquis | Apixaban | 508 | 85 |
| Tamsulosin Hcl | Tamsulosin Hcl | 459 | 84 |
| Metformin Hcl | Metformin Hcl | 446 | 117 |
| Gabapentin | Gabapentin | 438 | 106 |
| Escitalopram Oxalate | Escitalopram Oxalate | 430 | 84 |
| Losartan Potassium | Losartan Potassium | 413 | 109 |
| Mirtazapine | Mirtazapine | 413 | 84 |
| Alprazolam | Alprazolam | 377 | 103 |
| Omeprazole | Omeprazole | 366 | 115 |
| Furosemide | Furosemide | 352 | 76 |
| Famotidine | Famotidine | 333 | 70 |
| Pantoprazole Sodium | Pantoprazole Sodium | 321 | 119 |
| Sertraline Hcl | Sertraline Hcl | 303 | 72 |
| Lisinopril | Lisinopril | 300 | 71 |
| Carvedilol | Carvedilol | 296 | 68 |
| Metoprolol Tartrate | Metoprolol Tartrate | 295 | 61 |
| Montelukast Sodium | Montelukast Sodium | 290 | 107 |
| Simvastatin | Simvastatin | 281 | 66 |
| Quetiapine Fumarate | Quetiapine Fumarate | 265 | 24 |
| Divalproex Sodium | Divalproex Sodium | 237 | 26 |
| Trazodone Hcl | Trazodone Hcl | 236 | 65 |
| Oxycodone Hcl | Oxycodone Hcl | 217 | 35 |
| Mounjaro | Tirzepatide | 213 | 35 |
| Potassium Chloride | Potassium Chloride | 209 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 190 | 49 |
| Finasteride | Finasteride | 187 | 52 |
| Zolpidem Tartrate | Zolpidem Tartrate | 187 | 29 |
| Valsartan | Valsartan | 178 | 41 |
| Farxiga | Dapagliflozin Propanediol | 165 | 33 |
| Diclofenac Sodium | Diclofenac Sodium | 163 | 86 |
| Clonazepam | Clonazepam | 162 | 30 |
| Tizanidine Hcl | Tizanidine Hcl | 158 | 39 |
| Allopurinol | Allopurinol | 157 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 151 | 65 |
| Memantine Hcl | Memantine Hcl | 148 | 41 |
| Jardiance | Empagliflozin | 146 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 136 | 31 |
| Atenolol | Atenolol | 125 | 22 |
| Metolazone | Metolazone | 123 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 121 | 33 |
| Prednisone | Prednisone | 121 | 34 |
| Buspirone Hcl | Buspirone Hcl | 115 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 109 | 41 |
| Fluoxetine Hcl | Fluoxetine Hcl | 108 | 13 |
| Levetiracetam | Levetiracetam | 107 | 14 |
| Synjardy | Empagliflozin/Metformin Hcl | 105 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 103 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 101 | 27 |
| Gemtesa | Vibegron | 99 | suppressed |
| Celecoxib | Celecoxib | 97 | 35 |
| Diazepam | Diazepam | 95 | 29 |
| Lorazepam | Lorazepam | 95 | 20 |
| Baclofen | Baclofen | 91 | suppressed |
| Meloxicam | Meloxicam | 87 | 41 |
| Midodrine Hcl | Midodrine Hcl | 86 | 22 |
| Donepezil Hcl | Donepezil Hcl | 85 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 85 | 16 |
| Azithromycin | Azithromycin | 83 | 55 |
| Januvia | Sitagliptin Phosphate | 83 | 14 |
| Pregabalin | Pregabalin | 83 | 16 |
| Enalapril Maleate | Enalapril Maleate | 81 | 21 |
| Ezetimibe | Ezetimibe | 79 | 27 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 79 | 26 |
| Haloperidol Lactate | Haloperidol Lactate | 77 | suppressed |
| Spironolactone | Spironolactone | 77 | 18 |
| Labetalol Hcl | Labetalol Hcl | 74 | 13 |
| Ramipril | Ramipril | 74 | 19 |
| Lidocaine | Lidocaine | 73 | 21 |
| Bupropion Xl | Bupropion Hcl | 72 | 16 |
| Santyl | Collagenase Clostridium Hist. | 71 | 11 |
| Warfarin Sodium | Warfarin Sodium | 71 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 70 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 66 | 16 |
| Latanoprost | Latanoprost | 63 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 62 | 41 |
| Methocarbamol | Methocarbamol | 59 | 36 |
| Repaglinide | Repaglinide | 59 | 17 |
| Clonidine Hcl | Clonidine Hcl | 58 | suppressed |
| Ozempic | Semaglutide | 58 | 14 |
| Benztropine Mesylate | Benztropine Mesylate | 57 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 55 | suppressed |
| Risperidone | Risperidone | 55 | suppressed |
| Synthroid | Levothyroxine Sodium | 55 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 55 | 39 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | 12 |
| Lithium Carbonate | Lithium Carbonate | 52 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 52 | 28 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 52 | 19 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 51 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 51 | suppressed |
| Nystatin | Nystatin | 51 | 16 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 51 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 50 | 15 |
| Benazepril Hcl | Benazepril Hcl | 49 | 12 |
| Entresto | Sacubitril/Valsartan | 49 | suppressed |
| Olanzapine | Olanzapine | 49 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 48 | 16 |
| Aripiprazole | Aripiprazole | 46 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 45 | suppressed |
| Digoxin | Digoxin | 45 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 45 | 37 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 45 | 16 |
| Lactulose | Lactulose | 44 | 12 |
| Ibuprofen | Ibuprofen | 43 | 16 |
| Rybelsus | Semaglutide | 43 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 43 | 13 |
| Azelastine Hcl | Azelastine Hcl | 42 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | 12 |
| Meclizine Hcl | Meclizine Hcl | 42 | 25 |
| Mupirocin | Mupirocin | 42 | 27 |
| Oxycontin | Oxycodone Hcl | 41 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 40 | 12 |
| Cefuroxime | Cefuroxime Axetil | 39 | 34 |
| Ibandronate Sodium | Ibandronate Sodium | 39 | 15 |
| Sumatriptan Succinate | Sumatriptan Succinate | 39 | suppressed |
| Nystop | Nystatin | 38 | suppressed |
| Ursodiol | Ursodiol | 38 | suppressed |
| Xarelto | Rivaroxaban | 38 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | 12 |
| Nifedipine Er | Nifedipine | 37 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 36 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Lamotrigine | Lamotrigine | 35 | suppressed |
| Glimepiride | Glimepiride | 34 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 34 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 34 | 11 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 33 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 33 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 32 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 32 | suppressed |
| Permethrin | Permethrin | 32 | 27 |
| Hydromorphone Hcl | Hydromorphone Hcl | 31 | suppressed |
| Novolog Flexpen | Insulin Aspart | 31 | suppressed |
| Sucralfate | Sucralfate | 31 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 31 | 14 |
| Ondansetron Odt | Ondansetron | 30 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 29 | 13 |
| Haloperidol | Haloperidol | 29 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 28 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 28 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Torsemide | Torsemide | 28 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 27 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 27 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 18 |
| Telmisartan | Telmisartan | 27 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 27 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 26 | suppressed |
| Clozapine | Clozapine | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 14 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 26 | suppressed |
| Methimazole | Methimazole | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 26 | suppressed |
| Thiothixene | Thiothixene | 26 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 26 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 24 | suppressed |
| Colchicine | Colchicine | 24 | 11 |
| Isentress | Raltegravir Potassium | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 24 | 16 |
| Vascepa | Icosapent Ethyl | 24 | suppressed |
| Atazanavir Sulfate | Atazanavir Sulfate | 23 | suppressed |
| Budesonide | Budesonide | 23 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 23 | suppressed |
| Irbesartan | Irbesartan | 23 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | suppressed |
| Valproic Acid | Valproic Acid | 23 | suppressed |
| Amantadine | Amantadine Hcl | 22 | suppressed |
| Anastrozole | Anastrozole | 22 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Klor-Con M20 | Potassium Chloride | 22 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 22 | 11 |
| Ritonavir | Ritonavir | 22 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 21 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 20 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 20 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | 12 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Ssd | Silver Sulfadiazine | 17 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Nyamyc | Nystatin | 16 | suppressed |
| Restasis | Cyclosporine | 16 | suppressed |
| Tradjenta | Linagliptin | 16 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 16 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 15 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | 12 |
| Clotrimazole | Clotrimazole | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 11 |
| Liothyronine Sodium | Liothyronine Sodium | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Klor-Con M10 | Potassium Chloride | 13 | suppressed |
| Lamotrigine Er | Lamotrigine | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Nateglinide | Nateglinide | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.82 · 1 records | GlaxoSmithKline, LLC. | AREXVY, SHINGRIX | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error